Latest Close
$3.21
Stock Hub
SHPH
Shuttle Pharmaceuticals Holding
Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to treat cancers. It owns a pharmaceutical software artificial intelligence (AI) driven platform for molecular discovery and early-stage drug development. Use the sections below to move between chart, technical analysis, fundamentals, and news.
1y Change
-$37.69 (-92.15%)
Market Cap
$1,878,264.00
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Recommendation
none
52W Range
$2.58 to $55.90
Target Mean Price
Not available
Beta
1.22
Trailing P/E
32.10
Forward P/E
Not available
Price / Book
0.53
Company Overview
Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to treat cancers. It owns a pharmaceutical software artificial intelligence (AI) driven platform for molecular discovery and early-stage drug development. The company was founded in 2012 and is headquartered in Gaithersburg, Maryland.